The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts

Background: Newborn screening for congenital adrenal hyperplasia (CAH-NBS) is not yet a worldwide consensus, in part due to inconclusive evidence regarding cost-effectiveness because the analysis requires an understanding of the short- and long-term costs of care associated with delayed diagnosis. O...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pediatr
Autors principals: de Miranda, Mirela Costa, Haddad, Luciana Bertocco de Paiva, Trindade, Evelinda, Cassenote, Alex, Hayashi, Giselle Y., Damiani, Durval, Costa, Fernanda Cavalieri, Madureira, Guiomar, de Mendonca, Berenice Bilharinho, Bachega, Tania A. S. S.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Pediatrics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8183606/
https://ncbi.nlm.nih.gov/pubmed/34109139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fped.2021.659492
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars